These 4 Biotech Stocks Will Soar Under Obama
Contrarian Profits (January 13th, 2009) Writes:
Biotech companies are a great investment right now, says Laura Cadden. And support from the Obama administration will ensure this trend continues. Laura picks four small cap biotech firms set to soar.
This from Today’s Financial News:
We’ve already taken double-digit gains on Aastrom Biosciences, Inc. (NASDAQ:ASTM), Cerus Corporation (NASDAQ:CERS), and Geron Corporation (NASDAQ:GERN).
But these stocks are by no means done with their upward momentum.
Biotech companies continue to be a great investment – and these three are some of the best out there.
As the market takes another hit and these stocks artificially deflate, I recommend that TFN investors should again pick up shares.
And I’ve found another company that I believe is on the verge of a breakout.
But first, what’s so great about the three companies I selected in November? Let’s review… Aastrom Biosciences, Inc. (NASDAQ:ASTM) develops products for the repair or regeneration of human tissue. It’s
...Aastrom Biosciences Inc.;, biotech, cancer, cardiovascular disease, cell banking;, Cerus Corporation;, congestive heart failure;, contrarian profits, CRCs;, Cytori Therapeutics Inc.;, Dilated cardiomyopathy;, Europe, German Red Cross;, Geron Corporation;, GRN163L;, Heart Disease, Japan, Laura Cadden, Market Commentary, Merck, Middle East, mixed-cell products;, multiple myeloma, Obama administration, Spinal Cord Injury, Stem Cells, treatment of conditions such as cardiovascular disease;, tumor, U.S. Food and Drug Administration, United States, University of Oxford;, USD, Vaccines


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
